Yahoo
NasdaqGS - Delayed Quote USD

Align Technology, Inc. (ALGN)

158.64 -1.22 (-0.76%)
At close: September 4 at 4:00:01 PM EDT
158.64 0.00 (0.00%)
After hours: September 4 at 7:30:04 PM EDT
Trade ALGN on Coinbase
Chart Range Bar
Loading chart for ALGN

What's happening with ALGN?

21m ago
Powered by Yahoo Scout

Align Technology (ALGN) faces mixed market sentiment following its recent earnings report, with analysts expressing caution despite a consensus price target suggesting 30.6% upside. Recent leadership changes and ongoing legal victories in China may influence future performance.

Powered by Yahoo Scout
  • Previous Close 159.85
  • Open 157.67
  • Bid 146.08 x 200
  • Ask 169.78 x 200
  • Day's Range 155.24 - 160.49
  • 52 Week Range 122.00 - 200.44
  • Volume 990,515
  • Avg. Volume 957,628
  • Market Cap (intraday) 11.269B
  • Beta (5Y Monthly) 1.64
  • PE Ratio (TTM) 27.78
  • EPS (TTM) 5.71
  • Earnings Date Oct 28, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 208.60

Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products, Invisalign training, adjusting tools used by dental professionals during treatment, ancillary Invisalign accessory products, and other oral health products; Invisalign Professional Whitening system; Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; exocad, a computer-aided design and computer-aided manufacturing software; orthodontist software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers; and restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons. This segment also offers Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface for dental consultations; iTero TimeLapse technology for doctors or practitioners to compare a patient's historic 3D scans to the present-day scan; and subscription software, disposables, rents scanners, and pay per scan services. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.

www.aligntech.com

20,435

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Performance Overview

Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ALGN
1.59%
S&P 500 (^GSPC)
12.75%

1-Year Return

ALGN
17.77%
S&P 500 (^GSPC)
18.71%

3-Year Return

ALGN
57.69%
S&P 500 (^GSPC)
70.93%

5-Year Return

ALGN
78.01%
S&P 500 (^GSPC)
70.18%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 1.06B
Earnings 108.29M
Profit Margin 10.25%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
200M
400M
600M
800M
1B
6.0%
8.0%
10.0%
12.0%

Analyst Insights

View More

Top Analyst

Stifel
66/100
Latest Rating
Buy

Analyst Price Targets

170.00
208.60 Average
158.63 Current
240.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 7/23/2026
Analyst UBS
Rating Action Maintains
Rating Neutral
Price Action Raises
Price Target 186 -> 189

Statistics

View More

Valuation Measures

Annual
As of 9/2/2026
  • Market Cap

    11.31B

  • Enterprise Value

    10.32B

  • Trailing P/E

    27.63

  • Forward P/E

    12.53

  • PEG Ratio (5yr expected)

    0.67

  • Price/Sales (ttm)

    2.76

  • Price/Book (mrq)

    2.67

  • Enterprise Value/Revenue

    2.49

  • Enterprise Value/EBITDA

    11.39

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.99%

  • Return on Assets (ttm)

    7.40%

  • Return on Equity (ttm)

    10.15%

  • Revenue (ttm)

    4.14B

  • Net Income Avi to Common (ttm)

    413.58M

  • Diluted EPS (ttm)

    5.71

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.1B

  • Total Debt/Equity (mrq)

    2.86%

  • Levered Free Cash Flow (ttm)

    584.36M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

158.63 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • Lowering target price to $147.00

    ALIGN TECHNOLOGY INC has an Investment Rating of HOLD; a target price of $147.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Medium.

    Rating
    Price Target
  • Rating decreased to a HOLD

    ALIGN TECHNOLOGY INC has an Investment Rating of HOLD; a target price of $152.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Medium.

    Rating
    Price Target
  • Align Earnings: Mixed Results as Better-Than-Expected Case Volume Dimmed by Weak Scanners

    Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients’ teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

    Rating
    Price Target
  • Lowering target price to $188.00

    ALIGN TECHNOLOGY INC has an Investment Rating of BUY; a target price of $188.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Medium.

    Rating
    Price Target

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: